Wednesday, 10 July 2019
A new partnership between the Universities of Nottingham and Strathclyde and pharmaceutical company GSK will accelerate research into the discovery of new medicines.
The five-year ESPRC funded programme will see the partners deliver a new suite of methods and approaches to tackle some of the major challenges in the discovery, development, and manufacture of medicines. The total project funding is £12.9 million, including a £5.5 million grant award from the EPSRC.
The research programme aims to enable the production of transformative medicines at lower costs with reduced waste production and shorter time for manufacture.
Researchers will apply cutting edge Artificial Intelligence and machine-learning technologies to the efficient identification of next generation medicines.
They will also aim to improve the production process of medicines, with a focus on sustainability through reducing environmental impact, developing more efficient preparation methods, and improving equipment efficiency using digital manufacturing technologies.
The integration of the research undertaken in these areas combined with the world leading scientific expertise at each of the partner institutions will make a major contribution across the pharmaceutical sector and lead to the faster development of transformative medicines to help people do more, feel better and live longer.
In addition, the programme will train a cohort of outstanding postgraduate students and postdoctoral scientists who we expect to be future leaders either in industry or academia.
This is an incredibly exciting project for the University and strengthens our relationships with both GSK & the University of Strathclyde.
The University is committed to investment in world-leading discovery and in a highly-competitive field we have shown that our research and training environment offers unparalleled opportunities for us to help solve key challenges in the discovery, development and manufacture of medicines.
It is also tremendously exciting and gratifying that this government and industry investment is supporting key pillars of the University’s mission: to attract and retain world-class talent, and train and nurture the research leaders of tomorrow and make significant contributions to a globally competitive, agile and innovative UK economy, today and in the future.
Professor William Kerr, Partnership lead and Deputy Associate Principal for Research and Knowledge Exchange at the University of Strathclyde, said: “Escalation of research impact through external engagements and collaborations is a core and founding mission of the University of Strathclyde.
“Based on this, we are delighted to be embarking on this ambitious partnership, which will further elevate existing Strathclyde and Nottingham links with GSK, whilst also establishing synergistic new connections between the two universities.
“The programme will enable researchers in all three partners to deliver internationally-leading science of direct value to the pharmaceutical sector, whilst exploring new ways to connect research across all aspects of the drug discovery and manufacture process.”
Tony Wood, Senior Vice President, Medicinal Science & Technology at GSK said: “We are delighted with the EPSRC award which recognises the important work being done in collaboration with Nottingham and Strathclyde Universities.
“Together we are focused on the application of Artificial Intelligence/Machine Learning in synthetic chemistry, a discipline that is central to drug design and development of new medicines. The additional support will enable continued research hopefully delivering efficiency gains that bring meaningful benefit to the discovery of new medicines.”
More information is available from Dr Nicholas Bennett at the University of Nottingham Nicholas.Bennett@nottingham.ac.uk
Our academics can now be interviewed for broadcast via our Media Hub, which offers a Quicklink fixed camera and ISDN line facilities at Jubilee campus. For further information please contact a member of the Press Office on +44 (0)115 951 5798, email
For up to the minute media alerts,
follow us on Twitter
Notes to editors:
The University of Nottingham is a research-intensive university with a proud heritage. Studying at the University of Nottingham is a life-changing experience and we pride ourselves on unlocking the potential of our students. We have a pioneering spirit, expressed in the vision of our founder Sir Jesse Boot, which has seen us lead the way in establishing campuses in China and Malaysia - part of a globally connected network of education, research and industrial engagement. Ranked 103rd out of more than 1,000 institutions globally and 18th in the UK by the QS World University Rankings 2022, the University’s state-of-the-art facilities and inclusive and
disability sport provision is reflected in its crowning as The Times and Sunday Times Good University Guide 2021 Sports University of the Year. We are ranked eighth for research power in the UK according to
REF 2014. We have
six beacons of research excellence helping to transform lives and change the world; we are also a major employer and industry partner - locally and globally. Alongside Nottingham Trent University, we lead the Universities for Nottingham initiative, a pioneering collaboration which brings together the combined strength and civic missions of Nottingham’s two world-class universities and is working with local communities and partners to aid recovery and renewal following the COVID-19 pandemic.